Administrative Core The Administrative Core contains two components: administration and senior leadership. The research, clinical care, education, and outreach components of the University of Pittsburgh Cancer Institute?s (UPCI?s) mission are enabled by an efficient administrative infrastructure led by UPCI?s Associate Director for Research Administration, Maryann Donovan PhD, MPH, and the vision and guidance provided by UPCI?s experienced Senior Leadership, under UPCI Director, Nancy E. Davidson, MD.
The specific aims of administration are to: Refine administrative processes so that they are more effective and efficient, and less burdensome to UPCI Faculty and Leadership, 2) Adopt new technologies and tools for accomplishing administrative functions, and 3) Improve communication and streamline operations to improve services for researchers, including services provided by UPCI Shared Resources. In collaboration with UPCI, University of Pittsburgh, and UPMC departments, UPCI administration performs or assists in performing essential UPCI functions that include: budget preparation and expenditure monitoring; grant, contract and philanthropic funds management; space allocation and renovation; shared equipment purchase and operational management; shared resource operational management; faculty recruitments; meeting coordination; pilot project program development and implementation; planning and evaluation activities; UPCI membership maintenance and productivity tracking; and event and funding opportunity communications. UPCI?s Senior Leadership Group includes the Cancer Center Director (Dr. Davidson), UPCI Deputy Director (Edward Chu, MD), and the Associate Directors for Basic Research (Shivendra Singh, PhD), Translational Research (Robert L. Ferris, MD, PhD), Cancer Control and Population Sciences (Jian-Min Yuan, MD, PhD), Clinical Investigation (Adam Brufsky, MD, PhD), and Research Administration (Dr. Donovan). Individually accomplished, with strong scientific and leadership achievements, they have worked together as a Senior Leadership Group since 2012.
The specific aims for Senior Leadership are to: 1) Implement, continuously review, and refresh the 2014 Strategic Vision for UPCI, 2) Monitor progress at achieving the goals planned for the years 2014-2018, 3) Increase focus on translational advancement of discoveries made at UPCI, 4) Increase focus on research addressing UPCI?s catchment area, 5) Enable processes to support interaction with other Cancer Centers, and 6) Assist the Cancer Center Director in developing a vision for the years beyond 2018. During the current funding cycle Senior Leadership has developed and implemented an interactive vision-setting process for strategic planning; revised the process for oversight of Shared Resources; led, participated in, and promoted collaborative team science efforts directed at basic discovery and scientific advancement; and established new oversight committees to review and plan research that is focused on UPCI?s catchment area, and educational and training opportunities that strengthen UPCI?s Research Programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA047904-30S3
Application #
9759411
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Ptak, Krzysztof
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
30
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Ancevski Hunter, Katerina; Socinski, Mark A; Villaruz, Liza C (2018) PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer. Mol Diagn Ther 22:1-10
Luu, Thehang; Kim, Kyu-Pyo; Blanchard, Suzette et al. (2018) Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer. Breast Cancer Res Treat 167:469-478
Menk, Ashley V; Scharping, Nicole E; Moreci, Rebecca S et al. (2018) Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions. Cell Rep 22:1509-1521
Redner, Robert L; Beumer, Jan H; Kropf, Patricia et al. (2018) A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Leuk Lymphoma 59:2595-2601
Shayan, Gulidanna; Kansy, Benjamin A; Gibson, Sandra P et al. (2018) Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. Clin Cancer Res 24:62-72
Frahm, Krystle A; Waldman, Jacob K; Luthra, Soumya et al. (2018) A comparison of the sexually dimorphic dexamethasone transcriptome in mouse cerebral cortical and hypothalamic embryonic neural stem cells. Mol Cell Endocrinol 471:42-50
Pulopulos, Matias M; Vanderhasselt, Marie-Anne; De Raedt, Rudi (2018) Association between changes in heart rate variability during the anticipation of a stressful situation and the stress-induced cortisol response. Psychoneuroendocrinology 94:63-71
Shiffman, Saul; Scholl, Sarah M (2018) Three approaches to quantifying cigarette consumption: Data from nondaily smokers. Psychol Addict Behav 32:249-254
Samuelsson, Laura B; Bovbjerg, Dana H; Roecklein, Kathryn A et al. (2018) Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review. Neurosci Biobehav Rev 84:35-48
Chen, Dongshi; Ni, Hong-Min; Wang, Lei et al. (2018) PUMA induction mediates acetaminophen-induced necrosis and liver injury. Hepatology :

Showing the most recent 10 out of 1187 publications